Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹771 Cr.
Stock P/E
13.5
P/B
1.5
Current Price
₹25.7
Book Value
₹ 17.3
Face Value
1
52W High
₹33.2
52W Low
₹ 18.3
Dividend Yield
0%

Mukka Proteins Overview

Business

Mukka Proteins Ltd. is an Indian manufacturer and supplier of fish protein products. The company's core business involves processing fish into high-quality fish meal, fish oil, and allied products like fish soluble paste. These products serve as essential ingredients in the animal feed industry, primarily for aquaculture (aquafeed), poultry feed, and pet food manufacturers. The company's business model revolves around sourcing fresh fish, processing it in its facilities, and selling the derived protein products to both domestic and international customers.

Revenue Mix

Mukka Proteins' revenue is primarily generated from the sale of:

Fish Meal: Used as a protein-rich ingredient in aquafeed, poultry feed, and other animal feeds.

Fish Oil: Utilized for its Omega-3 fatty acid content in aquafeed, pharmaceutical, and nutraceutical industries, as well as in pet food.

Allied Products: Includes fish soluble paste and other by-products from the fish processing.

While specific percentage contributions are not consistently disclosed publicly post-listing, these three categories represent the entirety of their product offerings.

Industry

The company operates within the global animal feed industry, specifically focusing on marine-derived protein ingredients. This industry is driven by the demand for high-quality protein in animal nutrition. Mukka Proteins is positioned as one of India's leading manufacturers and exporters of fish meal and fish oil. It competes with other domestic and international players, differentiating itself through established supply chains, processing capabilities, and customer relationships across various geographies including Asia and the Middle East.

MOAT

Mukka Proteins possesses several advantages:

Scale and Integrated Operations: Significant manufacturing capacity in India and a degree of integration in its sourcing and processing operations can lead to cost efficiencies.

Established Supply Chain & Logistics: Long-standing relationships with fish suppliers and a robust distribution network for raw materials and finished products.

Customer Relationships: A diversified customer base with long-term relationships with domestic and international aquafeed, poultry feed, and pet food manufacturers.

Export Focus: A significant portion of its revenue comes from exports, diversifying its market exposure and reducing reliance on the domestic market alone.

Growth Drivers

Key factors that can drive growth for Mukka Proteins include:

Rising Global Protein Demand: Increasing global population and disposable incomes are expected to drive higher consumption of animal protein (fish, poultry), subsequently boosting demand for animal feed ingredients.

Growth in Aquaculture: The aquaculture sector continues to expand globally as a sustainable source of protein, directly increasing the need for fish meal and fish oil.

Expansion into New Markets/Products: Potential to expand into new geographical markets or further diversify its product offerings within the pet food or human nutraceutical segments.

Capacity Utilization & Efficiency: Optimizing existing capacity and potential future capacity expansions to meet growing demand.

Risks

Raw Material Price Volatility: Fluctuations in the availability and prices of fish (sardines, anchovies, etc.) due to environmental factors, fishing quotas, or seasonality can impact profitability.

Regulatory & Environmental Risks: Changes in fishing regulations, environmental protection laws, and import/export policies in key markets could affect operations.

Disease Outbreaks: Outbreaks of diseases in aquaculture or poultry can reduce demand for animal feed.

Competition: Intense competition from other fish meal and fish oil manufacturers, as well as alternative protein sources (e.g., soy protein, insect meal).

Foreign Exchange Fluctuations: As a significant exporter and importer, the company is exposed to currency exchange rate risks.

Management & Ownership

Mukka Proteins is promoted by Kalandan Mohammed Haris, Kalandan Mohammed Arif, and Kalandan Mohammed Althaf, who are actively involved in the company's operations and have extensive experience in the marine products industry. The company is family-led, with the promoter group holding a significant stake in the company post its public listing. This indicates a strong alignment of interests between management and shareholders.

Outlook

Mukka Proteins operates in a structurally growing industry driven by increasing global protein consumption. The company's established position as a key manufacturer and exporter of marine-derived protein ingredients for animal feed positions it to benefit from the expansion of the aquaculture and poultry sectors. However, the business is susceptible to commodity price volatility for its raw materials, regulatory changes concerning fishing and environmental norms, and intense competition from both marine and alternative protein sources. Its ability to navigate these challenges while capitalizing on rising global demand for feed ingredients will be crucial for sustained performance.

Mukka Proteins Share Price

Live · BSE / NSE · Inception: 2010
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Mukka Proteins Quarterly Results

#(Fig in Cr.) Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 257 172 149 303 382 171 245 653 381 490
Other Income 3 3 3 6 4 3 6 5 15 2
Total Income 260 175 152 309 386 173 251 658 396 491
Total Expenditure 225 158 140 262 352 156 224 608 347 442
Operating Profit 35 17 13 47 33 17 27 50 49 50
Interest 7 8 9 11 10 11 13 15 15 16
Depreciation 3 3 4 4 3 3 4 4 5 5
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 26 6 0 32 20 3 10 32 29 28
Provision for Tax -2 0 -0 6 6 1 2 7 8 9
Profit After Tax 28 5 1 26 14 2 7 24 21 20
Adjustments -1 -1 1 -0 -1 -1 -1 -1 -1 -1
Profit After Adjustments 27 4 2 26 14 2 6 24 21 19
Adjusted Earnings Per Share 0.9 0.1 0.1 0.9 0.5 0.1 0.2 0.8 0.7 0.6

Mukka Proteins Profit & Loss

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Net Sales 409 549 604 771 1177 1380 1006 1449 1769
Other Income 3 8 10 7 7 17 15 29 28
Total Income 412 557 614 778 1184 1397 1022 1478 1796
Total Expenditure 385 525 582 724 1091 1274 912 1335 1621
Operating Profit 26 32 32 54 93 123 110 143 176
Interest 4 7 8 10 16 26 37 54 59
Depreciation 2 5 8 9 12 12 14 17 18
Exceptional Income / Expenses -1 0 0 0 0 0 0 0 0
Profit Before Tax 19 20 15 36 66 87 60 75 99
Provision for Tax 5 6 4 10 18 13 12 18 26
Profit After Tax 14 14 11 26 48 74 48 57 72
Adjustments 1 -0 -2 -2 -3 -4 -2 -5 -4
Profit After Adjustments 14 13 9 24 44 70 46 52 70
Adjusted Earnings Per Share 0.6 0.6 0.4 1.1 2 2.3 1.5 1.7 2.3

Mukka Proteins Balance Sheet

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Shareholder's Funds 44 57 67 98 148 396 441 499
Minority's Interest 0 1 3 5 8 12 16 30
Borrowings 16 14 9 9 5 6 3 32
Other Non-Current Liabilities 3 4 4 6 11 5 7 11
Total Current Liabilities 137 217 272 274 403 521 610 1049
Total Liabilities 201 293 355 392 575 941 1076 1621
Fixed Assets 48 77 78 81 83 84 93 193
Other Non-Current Assets 11 10 20 25 28 41 58 139
Total Current Assets 142 206 257 286 464 817 926 1289
Total Assets 201 293 355 392 575 941 1076 1621

Mukka Proteins Cash Flow

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Opening Cash & Cash Equivalents 10 1 1 3 12 27 94 3
Cash Flow from Operating Activities -20 -25 2 5 -56 -150 -112 -111
Cash Flow from Investing Activities -23 -28 -14 -11 -3 -48 -35 -146
Cash Flow from Financing Activities 34 54 13 15 75 266 56 267
Net Cash Inflow / Outflow -9 1 2 8 15 68 -91 10
Closing Cash & Cash Equivalent 1 2 3 12 27 94 3 13

Mukka Proteins Ratios

# Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Earnings Per Share (Rs) 0.65 0.6 0.41 1.1 2 2.34 1.55 1.74
CEPS(Rs) 0.73 0.83 0.88 1.56 2.7 2.89 2.05 2.46
DPS(Rs) 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 2 2.57 3.02 4.47 6.72 13.2 14.69 16.64
Core EBITDA Margin(%) 5.71 4.33 3.62 6.07 7.11 7.49 9.25 7.74
EBIT Margin(%) 5.66 4.9 3.89 5.93 6.8 8.06 9.5 8.7
Pre Tax Margin(%) 4.6 3.59 2.56 4.67 5.44 6.21 5.87 5.08
PAT Margin (%) 3.35 2.47 1.82 3.35 3.92 5.28 4.69 3.86
Cash Profit Margin (%) 3.94 3.33 3.21 4.46 4.9 6.16 6.01 4.98
ROA(%) 6.81 5.5 3.4 6.91 9.82 9.8 4.77 4.23
ROE(%) 31.1 27 17.89 31.32 38.61 27.32 11.5 12.15
ROCE(%) 18.24 16.57 11.08 18.35 24.44 19.54 11.82 11.93
Receivable days 25.44 21.1 25.05 25.87 26.3 38.72 68.51 47.06
Inventory Days 80.39 68.16 80.08 74.55 59.45 84.67 175.65 175.18
Payable days 62.95 54.51 64.49 56.82 44.27 42.92 65.49 59.68
PER(x) 0 0 0 0 0 15.62 21.12 10.6
Price/Book(x) 0 0 0 0 0 2.76 2.23 1.11
Dividend Yield(%) 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.21 0.26 0.27 0.24 0.21 0.96 1.38 0.87
EV/Core EBITDA(x) 3.33 4.6 5.04 3.35 2.67 10.84 12.63 8.79
Net Sales Growth(%) 0 34.36 9.94 27.6 52.77 17.22 -27.06 44.02
EBIT Growth(%) 0 16.41 -12.85 94.49 80.51 37.59 -14.01 32.02
PAT Growth(%) 0 -0.78 -18.89 134.5 84.07 56.35 -35.27 18.69
EPS Growth(%) 0 -7.8 -31.88 169.71 82.06 16.56 -33.68 12.06
Debt/Equity(x) 1.88 2.51 2.39 1.76 1.72 0.91 1.02 1.54
Current Ratio(x) 1.04 0.95 0.95 1.05 1.15 1.57 1.52 1.23
Quick Ratio(x) 0.38 0.42 0.39 0.44 0.58 0.75 0.59 0.41
Interest Cover(x) 5.33 3.74 2.93 4.72 5 4.37 2.62 2.4
Total Debt/Mcap(x) 0 0 0 0 0 0.33 0.46 1.39

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +44% +7% +19% —
Operating Profit CAGR +30% +15% +35% —
PAT CAGR +19% +6% +39% —
Share Price CAGR -4% — — —
ROE Average +12% +17% +24% +25%
ROCE Average +12% +14% +17% +17%

Mukka Proteins Shareholding Pattern

Latest · Jun 2026
100% held
Promoters 73.33 %
FII 1.73 %
DII (MF + Insurance) 0 %
Public (retail) 24.93 %
Others 0.01 %
# Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Promoter 73.3373.3373.3373.3373.3373.3373.3373.3373.3373.33
FII 6.465.082.822.632.632.081.71.71.71.73
DII 22.521.981.981.871.660.1700
Public 18.219.0921.8522.0622.0522.7123.3124.824.9724.93
Others 0000000000
Total 100100100100100100100100100100

Mukka Proteins Peer Comparison

Animal Feed Edit Columns

Mukka Proteins Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Mukka Proteins Pros & Cons

Pros

  • Company has delivered good profit growth of 38% CAGR over last 5 years
  • Debtor days have improved from 65.49 to 59.68days.

Cons

Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp